UK approves Pfizer jab for use in 12-15-year-olds
- 3 years ago
- International
The UK has approved the use of the Pfizer-BioNTech vaccine in children aged 12-15, saying it is safe and effective in this age group and the
The UK has approved the use of the Pfizer-BioNTech vaccine in children aged 12-15, saying it is safe and effective in this age group and the
Pfizer Inc and its German partner BioNTech SE said on Friday they have requested the U.S. Food and Drug Administration to expand the emergency use
Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that
The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil,
Pfizer Inc and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first
In implementation of the directives of His Highness The Amir Sheikh Tamim bin Hamad Al Thani regarding the arrival of the first shipment of the
I feel so privileged to be the first person vaccinated against Covid-19, said Margaret Keenan Keenan received the jab at her local
A United States biotech company, that interim data from its ongoing trials shows its COVID-19 vaccine is 95 percent effective, Dr. Abd
REUTERS
U.S. and European regulators could approve Pfizer and BioNTech’s experimental COVID-19 vaccine as early as mid-December,
BioNTech’s CEO Ugur Sahin says he is confident vaccine can ‘bash the virus over the head’.
The man behind the first
REUTERS
Pfizer Inc and BioNTech SE on Saturday proposed to the U.S Food and Drug Administration (FDA) to expand their Phase 3 pivotal
By James Paton, Riley Griffin, and Robert Langreth,